EAPCI Column

DOI:

EAPCI focus on the Patient Advocacy Committee: an interview with the Chair, Stéphane Manzo-Silberman

What is the role of the Committee?

The EAPCI Patient Advocacy Committee's main aim is to put patients' interests at the heart of the care provided by interventional cardiology teams. We want to strengthen patient participation by not only ensuring they understand the diagnostic and therapeutic strategies proposed, but by also improving the quality of information they receive. We aim to improve our understanding of the patient’s needs in order to better our diagnostic capabilities, therapeutic solutions and optimise follow-ups. The Committee benefits from the knowledge and experience of interventional cardiology professionals with diverse backgrounds in terms of expertise, seniority, country of origin, including nurses and allied professionals as well as expert patients. The Committee's role is to define the needs in terms of patient information and to improve communication between patients and the cardiology care team. The Committee is also devoted to supporting the dissemination of information to patients to improve their experience of interventional procedures, to promote specific actions in understudied and/or underrepresented populations and to work closely with the ESC Patient Forum.

How does the Committee benefit both the interventional cardiologist and the patient?

The previous committee developed patient information videos explaining various interventional procedures (coronary angiogram, PCI, TAVI, TEER and LAAO) in several languages which we will continue to promote to the community and evaluate how to extend and translate into other languages. The Committee also aims to increase cardiologists’ awareness of patient experience, perception and feedback. A patient-reported experience measurement (PREM) questionnaire has been drafted and is now available in ten different languages. The European Patient Experience in the Catheterization Laboratory (PATCATH) questionnaire helps us  to understand and improve patients’ experiences while undergoing catheterisation laboratory-based procedures. These tools may improve the quality of the communication between patient and professionals, facilitate exchanges and optimise mutual understanding.

What are the key projects you are working on during your term?

The key projects were defined by the Committee Co-Chair,  Joanna Wykrzykowska, in conjunction with EAPCI Advocacy and Regulatory Affairs Pillar Chair, Marie-Claude Morice. We have planned a patient feedback survey that will help to explore communication and comprehension of their disease and symptoms. This survey will provide original insight into how we can improve patient symptom evaluation and our communication. Specifically, regarding women, we are discussing how EAPCI can optimise its participation in trials, improve awareness of and access to cardiovascular procedures and ensure optimised follow-up programmes. Future work will involve liaising with our colleagues in EAPCI. Finally, the last, but not least, topic is a survey for patients with structural diseases to better understand their reporting and definition of symptoms, to evaluate the possible sex differences in their description and/or recognition of symptoms and diagnosis. This information could then enable the development of an aortic stenosis-specific quality of life questionnaire (as a template for other valvular diseases).

How can EAPCI members become involved in the work of the Committee?

To realise this ambitious program, all Committee members are of course very actively involved, and above all we want to establish a close collaboration with other Committees, such as the EAPCI Nurses & Allied Professionals Committee, the EAPCI Gender and Disparities Committee,  the EAPCI Young Committee, and the EAPCI Valvular and Structural Heart Interventions Committee, among others, in order to achieve the most integrative synergy of skills and viewpoints possible.

Volume 21 Number 4
Feb 17, 2025
Volume 21 Number 4
View full issue

Trending articles
167.3

Expert review

10.4244/EIJ-D-21-00690 May 15, 2022
Crush techniques for percutaneous coronary intervention of bifurcation lesions
Moroni F et al
free
73.05

State-of-the-Art

10.4244/EIJ-D-24-00386 Feb 3, 2025
Mechanical circulatory support for complex, high-risk percutaneous coronary intervention
Ferro E et al
free
60.55

State-of-the-Art

10.4244/EIJ-D-24-00066 Apr 21, 2025
Management of complications after valvular interventions
Bansal A et al
free
58.3

Clinical research

10.4244/EIJ-D-23-00344 Sep 18, 2023
Clinical outcomes of TAVI with the Myval balloon-expandable valve for non-calcified aortic regurgitation
Sanchez-Luna JP et al
free
33.9

CLINICAL RESEARCH

10.4244/EIJ-D-17-00381 Oct 11, 2017
Stent malapposition and the risk of stent thrombosis: mechanistic insights from an in vitro model
Foin N et al
free
33.65

State-of-the-Art

10.4244/EIJ-D-23-00606 Jan 1, 2024
Targeting inflammation in atherosclerosis: overview, strategy and directions
Waksman R et al
free
25.5

Expert Review

10.4244/EIJ-D-24-00535 May 5, 2025
Catheter-based techniques for pulmonary embolism treatment
Costa F et al
23.55

Expert Review

10.4244/EIJ-D-23-00700 Feb 19, 2024
Evolving indications for transcatheter mitral edge-to-edge repair
Shuvy M and Maisano F
free
X

The Official Journal of EuroPCR and the European Association of Percutaneous Cardiovascular Interventions (EAPCI)

EuroPCR EAPCI
PCR ESC
Impact factor: 7.6
2023 Journal Citation Reports®
Science Edition (Clarivate Analytics, 2024)
Online ISSN 1969-6213 - Print ISSN 1774-024X
© 2005-2025 Europa Group - All rights reserved